Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Gonzalez-Cao M, Mayo de Las Casas C, Oramas J, Berciano-Guerrero MA, de la Cruz L, Cerezuela P, Arance A, Muñoz-Couselo E, Espinosa E, Puertolas T, Diaz Beveridge R, Ochenduszko S, Villanueva MJ, Basterretxea L, Bellido L, Rodriguez D, Campos B, Montagut C, Drozdowskyj A, Molina MA, Lopez-Martin JA, Berrocal A.
Gonzalez-Cao M, et al. Among authors: basterretxea l.
Nat Commun. 2021 Dec 1;12(1):7008. doi: 10.1038/s41467-021-26572-6.
Nat Commun. 2021.
PMID: 34853302
Free PMC article.
Clinical Trial.